Acute Vasculitis, Kawasaki Disease and Covid 19
Keywords:
VASCULITIS, INFLAMMATION, MUCOCUTANEOUS LYMPH NODE SYNDROME, COVID 19.Abstract
Introduction: Acute vasculitides in childhood comprise a group of diseases characterized by inflammation of blood vessels. They have been observed in patients with SARS-CoV-2 infection and the cutaneous lesions presented are related to Kawasaki disease.
Objective: to review vasculitis, Kawasaki disease and skin lesions reported in Covid 19 infection.
Methods: A search on vasculitis was performed in Pub Med, WHO-2020, Scielo, Swisslinx, Dialnet, Redalyc journals. We selected all those documents that included the word vasculitis, Kawasaki disease and Covid 19, published in the last 5 years.
Development: Multiple studies and research are still being carried out to clarify the etiology and pathophysiological mechanisms of vasculitis. Diagnosis and therapeutic conduct require multidisciplinary intervention. They are infrequent diseases in pediatric age, being Kawasaki disease one of the best known. It is of vital importance to know about it, in order to achieve an early diagnosis and timely treatment to reduce the risk of complications in the patient. In the current context of the Covid-19 pandemic, variations in the behavior of Kawasaki disease have been reported, which constitutes a challenge for researchers and for all health personnel who provide medical care to these children.
Conclusions. This review addresses the fundamental elements on Kawasaki and its modifications in SARS-CoV-2 infected patients, which in the current pandemic are essential in the teaching and care activity.
Downloads
References
1. Morel Z. Clasificación de las Vasculitis Sistémicas en Pediatría. Pediatr. (Asunción) [Internet]. 2012 Ago [citado 08/12/2021]; 39(2): 121-130. Disponible en: https://www.revistaspp.org/index.php/pediatria/article/view/47
2. Chércoles LE, Fong JA. Algunas especificidades sobre las vasculitis. MEDISAN [Internet]. 2016 [citado 08/12/2021]; 20(11): 2395-2409. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016001100011&lng=es.
3. Chanussot C, Vega ME, Flores L, Ríos C, Cabiedes J, Reyes E. Etiología de las vasculitis cutáneas: utilidad de una aproximación sistémica. Gaceta Médica de México [Internet]. 2018 [citado 08/12/2021]; 154(1): 62-67. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=79025
4. Camacho MS, Lirola MJ. Púrpura de Shönlein-Henoch, enfermedad de Kawasaki y otras vasculitis. Pediatr Integral [Internet]. 2017 [citado 08/12/2021]; XXI(3): 183-195. Disponible en: https://www.pediatriaintegral.es/wp-content/uploads/2017/xxi03/04/n3-183-195_M-Camacho.pdf.
5. Polo M, Montiel J, Batista V, Contreras N, Conde GC. COVID-19, enfermedad de Kawasaki y síndromes inflamatorios multisistémicos: una conceptualización desde los principales reportes. Med Int Méx [Internet]. 2021 [citado 02/11/2021]; 37(3): 373-382. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2021/mim213h.pdf
6. Fundación Española de Reumatología. Vasculitis [Internet]. 2020 [citado 20/11/2021]. Disponible en: https://inforeuma.com/enfermedades-reumaticas/vasculitis/tipos-de-vasculitis/.
7. Espígol G, Prieto S, Hernández J .Cid Xutglá MC. Protocolo diagnóstico de las vasculitis sistémicas. Medicine [Internet]. 2017 [citado 20/11/2021]; 12(29): 1739-43. Disponible en: https://www.researchgate.net/publication/315448474
8. Robert M, Joseph W, Nathan J, Samir S, Robert C, Karen M. Nelson. Tratado de pediatría, 21ª. ed. t-1.Elsevier España; 2020. p. 1316-1327.
9. Printo P. Vasculitis sistémica primaria juvenil rara [Internet]. 2016 [citado 20/11/2021]. Disponible en: https://www.printo.it/pediatric-rheumatology/SV/intro
10. Alcobendas RM, Remesal A, Fernández P. Vasculitis asociadas a ANCA positivo. Protoc diagn ter pediatr [Internet]. 2020 [citado 20/11/2021]; 2: 239-248. Disponible en: https://www.aeped.es/sites/default/files/documentos/21_vasculitis_anca.pdf
11. Villa A. Vasculitiscutánea. Manual MSD [Internet]. 2020 Jul [citado 10/12/2021]. . Disponible en: https://www.msdmanuals.com/es/professional/trastornos-de-los-tejidos-musculoesquelético-y-conectivo/vasculitis/vasculitis-cutánea
12. Duarte MA, Cifuentes S, Arias L. Manifestaciones imagenológicas pulmonares y abdominales de las vasculitis primarias. Rev. Colomb. Radiol [Internet]. 2020 [citado 10/12/2021]; 31(3): 5389-95. Disponible en: https://www.webcir.org/revistavirtual/articulos/2021/5_junio/col/manifestaciones_vasculitis_primarias.pdf
13. Borlán S. Vasculitis por IgA (púrpura de Schönlein-Henoch). Protocdiagn ter pediatr [Internet]. 2020 [citado 10/12/2021]; 2: 225-238. Disponible en: https://www.aeped.es/sites/default/files/documentos/20_vasculitis_iga.pdf
14. Sánchez LM, Navarrete J, Hernández SJ, Vallejo JC. Causa de la vasculitis leucocitoclástica en niños y adultos. Dermatol Rev Mex [Internet]. 2020 Mar-Abr [citado 10/12/2021]; 64(2): 122-128. Disponible en: https://dermatologiarevistamexicana.org.mx/article/causa-de-la-vasculitis-leucocitoclastica-en-ninos-y-adultos/
15. Sánchez J. Enfermedad de Kawasaki. Protoc diagn ter pediatr [Internet]. 2020 [citado 12/05/2021]; 2: 213-224. Disponible en: https://www.aeped.es/sites/default/files/documentos/19_kawasaki.pdf.
16. Cortés N, De La Maza F, Díaz J, Domínguez A, Bruna S, Velásquez Díaz A. Actualización en enfermedad de kawasaki: diagnóstico, estudio y tratamiento. Rev Ped Elec [Internet]. 2020 [citado 02/11/2021]; 17(1): 1-6. Disponible en: http://www.revistapediatria.cl/volumenes/2020/vol17num1/pdf/ACTUALIZACION%20EN%20ENFERMEDAD%20DE%20KAWASAKI%20DIAGNOSTICO%20ESTUDIO%20TRATAMIENTO.pdf
17. Blanco R, Narváez J. Vasculitis. Dossier de prensa [Internet]. 2020 [citado 20/11/2021]. Disponible en: http://docplayer.es/24541949-Vasculitis-dossier-de-prensa.html.
18. Minchala RE, Ramírez AA, Encalada BJ, Cáceres SG, Estrella MA, Minchala MA, et al. Enfermedad de Kawasaki asociada a COVID-19: Revisión Sistemática. Archivos Venezolanos de Farmacología y Terapéutica [Internet]. 2020 [citado 02/11/2021]; 39(8): 935-940. Disponible en: https://www.redalyc.org/journal/559/55969796003/html/
19. Hameed S, Elbaaly H, Catriona EL. Spectrum of Imaging Findings at Chest Radiography, US, CT, and MRI in Multisystem Inflammatory Syndrome in Children Associated with COVID-19 [Internet]. 2020 [citado 02/11/2021]; 298(1). Disponible en: https://doi.org/10.1148/radiol.2020202543.
20. Rodríguez R, Rivera M. Síndrome inflamatorio multisistémico asociado a COVID-19. Rev Latin Infect Pediatr [Internet]. 2020 [citado 02/11/2021]; 33(3): 115-118. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=95645.
21. Taffarel P, Jorro Barón F, Rodríguez AP, Widmer J, Meregalli C. Síndrome inflamatorio multisistémico en niños, relacionado con COVID-19: actualización a propósito de la presentación de 2 pacientes críticos. Arch Argent Pediatr [Internet]. 2021 [citado 08/12/2021]; 19(1):e26-e35. Disponible en: https://www.sap.org.ar/docs/publicaciones/archivosarg/2021/v119n1a18.pdf
22. D’Antiga L. Enfermedad grave similar a la vasculitis de kawasaki en COVID-19. [Internet]. Italia: Hospital Papa Giovanni XXII; 2020 [citado 08/12/2021]. Disponible en: https://www.siicsalud.com/dato/resiic.php/163736.
23. Lara AP, Salamea AC, Chacón IP, Pacheco B, Ardila MA, Guerrero I. COVID-19 y síndrome inflamatorio multisistémico en niños. Revista Latinoamericana de Hipertensión [Internet]. 2021 [citado 08/12/2021]; 16(2):168-172. Disponible en: https://www.redalyc.org/journal/1702/170269310011/170269310011.pdf
24. Nakandakari MD, Marín H, Seminario R. Vasculitis por IGA (Púrpura de HenochSchönlein) en un paciente pediátrico con COVID-19 Y Estrongiloidiasis. Reporte de caso. Rev Fac Med Hum [Internet]. 2021 Ene [citado 10/12/2021]; 21(1): 199-205. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312021000100199&lng=es
25. Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 08/01/2022]; 34(5): 212-213 Disponible en: http://dx.doi.org/10.1111/jdv.16387
26. De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y, et al. Cutaneous manifestations related to coronavirus disease. 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol [Internet]. 2020 [citado 08/01/2022]; 83(2): 674-675. Disponible en: http://dx.doi.org/10.1016/j.jaad.2020.05.073
27. Adhikari SP, Meng S, Wu YJ, Yu-Ping M, Rui-Xue Y, Qing-Zhi W, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious Diseases of Poverty Journal [Internet]. 2020 [citado 08/01/2022]; 9(29). Disponible en: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-020-00646-x
28. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 02/11/2021]; 34(6): 244-245. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32294273/
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
